There are 2789 resources available
438P - First line treatment patterns in BRAFV600E-mutant metastatic colorectal cancer patients (mCRC): The CAPSTAN European retrospective study
Presenter: Bernard Asselain
Session: ePoster Display
398P - AI-powered whole-slide image analysis of tumor-infiltrating lymphocytes for prediction of prognosis in colorectal cancer
Presenter: Changhee Park
Session: ePoster Display
399P - Functional MRI in locally advanced rectal cancer: Can novel MRI techniques predict response to total neoadjuvant therapy?
Presenter: Gehan Khedr
Session: ePoster Display
400P - Baseline expression of RAD23B protein in circulating tumor cells correlates with complete pathological response of neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Presenter: Virgilio E Silva
Session: ePoster Display
401P - Translation of the IDEA trial into clinical practice: Evaluation of implementation of a new guideline
Presenter: Karlijn Rooijen van
Session: ePoster Display
442P - A phase I-II multicenter trial with avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients. GEMCAD 16-02 (AVEVAC trial)
Presenter: Marta Español-Rego
Session: ePoster Display
443P - EMERGE: A phase II trial assessing the efficacy of domatinostat plus avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal cancers – phase IIA dose finding
Presenter: Elizabeth Cartwright
Session: ePoster Display
939P - Phase II study of pembrolizumab (pembro) and bavituximab (bavi) in advanced hepatocellular carcinoma (HCC)
Presenter: David Hsiehchen
Session: ePoster Display
940P - Dose-escalation trial of OBP-301, novel telomerase-specific oncolytic virus in advanced hepatocellular carcinoma
Presenter: Jeong Heo
Session: ePoster Display